Pharmaceutical Investing Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET
Pharmaceutical Investing Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm
SAGA Metals Mobilizes Final Team for Major Drill Program at Radar Project in Labrador, Targeting Maiden Mineral Resource Estimate & Provides Corporate Update
